ProQR Therapeutics Q3 EPS $(0.10), Inline, Sales $2.882M Miss $8.550M Estimate
Benzinga Newsdesk 12 months ago
EarningsEarnings MissesNews
ProQR Therapeutics (NASDAQ:PRQR) reported quarterly losses of $(0.10) per share which met the analyst consensus estimate. This is a 9.09 percent increase over losses of $(0.11) per share from the same period last year.
ProQR Therapeutics (NASDAQ:PRQR) reported quarterly losses of $(0.10) per share which met the analyst consensus estimate. This is a 9.09 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $2.882 million which missed the analyst consensus estimate of $8.550 million by 66.29 percent. This is a 31.77 percent decrease over sales of $4.224 million the same period last year.